Dr. Paul Thielking, MD (He/Him)

Dr. Paul Thielking, MD (He/Him), Chief Science Officer
Certified psychiatry, hospice/palliative medicine, and integrative medicine leader and trained in psychedelic therapy (CIIS). Extensive experience developing interventions for people with serious illness and substance use disorders, including psilocybin for depression in cancer patients, ketamine for opioid use, and tobacco treatment. Dr. Thielking was previously Chief Scientific Officer at Novamind.